LAB FY 2012 Earnings — Standard BioTools Inc. Revenue & Financial Results | Market Cap Arena

LABStandard BioTools Inc.

$374M

FY 2012 Earnings

Healthcare Medical - Devices

Income Statement

Revenue

$52M+22.1% YoY

Gross Profit

$37M70.7% margin

Operating Income

-$18M-34.5% margin

Net Income

-$19M-36.4% margin

EPS (Diluted)

$-0.86

Cash Flow

Operating Cash Flow

-$17M

Free Cash Flow

-$20M

Stock-Based Comp.

$4M

Balance Sheet

Total Assets

$114M

Total Liabilities

$13M

Stockholders' Equity

$101M

Cash & Equivalents

$59M

Year-over-Year Comparison

Metric	Current	Year Ago	Change
Revenue	$52M	$43M	+22.1%
Gross Profit	$37M	$30M	+24.7%
Operating Income	-$18M	-$19M	+2.7%
Net Income	-$19M	-$22M	+15.3%